In vivo targeting of human neutralizing antibodies against CD55 and CD59 to lymphoma cells increases the antitumor activity of rituximab

Claudio Tripodo, Francesco Tedesco, Paolo Macor, Roberto Marzari, Sonia Zorzet, Erich Piovan, Alberto Amadori, Fleur Bossi

Risultato della ricerca: Articlepeer review

117 Citazioni (Scopus)

Fingerprint

Entra nei temi di ricerca di 'In vivo targeting of human neutralizing antibodies against CD55 and CD59 to lymphoma cells increases the antitumor activity of rituximab'. Insieme formano una fingerprint unica.

Medicine & Life Sciences